Our report seeks to align with the Sustainability Accounting Standards Board (SASB) Healthcare – Biotechnology & Pharmaceuticals industry standards, the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations, as well as considering additional topics deemed relevant by Elanco and our key stakeholders.